Apo-Pramipexole 0.25 mg

APO-PRAMIPEXOLE 0.25 MG tablets contain pramipexole dihydrochloride monohydrate, a medication used to manage symptoms of Parkinson's disease and restless legs syndrome. This oral tablet is manufactured by Apotex Inc. in Canada.

APO-PRAMIPEXOLE 0.25 MG tablets are commonly used to alleviate symptoms associated with Parkinson's disease, such as tremors, stiffness, and poor muscle control. Additionally, this medication may be prescribed to treat restless legs syndrome, helping to reduce the urge to move the legs. Pramipexole works by affecting the balance of natural substances in the brain, which can improve movement and reduce discomfort.

Common effects of APO-PRAMIPEXOLE 0.25 MG tablets may include nausea, dizziness, and fatigue. Some users might experience headaches or drowsiness. These effects can vary from person to person and may subside as the body adjusts to the medication.

APO-PRAMIPEXOLE 0.25 MG tablets should be handled with care. It is important to follow the guidance of a healthcare professional regarding usage and storage. Avoid sudden discontinuation without consulting a healthcare provider. Keep the medication out of reach of children and store it as directed.

APO-PRAMIPEXOLE 0.25 MG tablets may interact with certain medications, including those that affect the central nervous system. Alcohol and other depressants should be avoided as they can enhance the sedative effects. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.